Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MERTK Antikörper (Extracellular) (FITC)

Der Kaninchen Polyklonal Anti-MERTK-Antikörper wurde für FACS und LCI validiert. Er ist geeignet, MERTK in Proben von Maus zu detektieren.
Produktnummer ABIN7237599

Kurzübersicht für MERTK Antikörper (Extracellular) (FITC) (ABIN7237599)

Target

Alle MERTK Antikörper anzeigen
MERTK (C-Mer Proto-Oncogene Tyrosine Kinase (MERTK))

Reaktivität

  • 95
  • 36
  • 26
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Maus

Wirt

  • 67
  • 32
  • 2
  • 2
  • 1
Kaninchen

Klonalität

  • 59
  • 45
Polyklonal

Konjugat

  • 59
  • 10
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Dieser MERTK Antikörper ist konjugiert mit FITC

Applikation

  • 55
  • 52
  • 46
  • 20
  • 15
  • 14
  • 13
  • 10
  • 9
  • 8
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Live Cell Imaging (LCI)
  • Bindungsspezifität

    • 23
    • 13
    • 8
    • 8
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 402-416, Extracellular

    Verwendungszweck

    A Rabbit Polyclonal Antibody to MERTK (extracellular) conjugated to the fluorescent dye FITC

    Spezifität

    Extracellular, N-terminus.

    Kreuzreaktivität

    Human, Maus, Ratte

    Homologie

    Rat - identical, human - 13,15 amino acid residues identical

    Produktmerkmale

    Extracellular, N-terminus

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)KPPIKRQDGELVGYR, corresponding to amino acid residues 402 - 416 of mouse MERTK

    Isotyp

    IgG
  • Applikationshinweise

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: N/A

    Application Dilutions Western blot wb: N/A

    Kommentare

    Negative Control: (ABIN7582044)

    Blocking Peptide: (ABIN7234888)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Recosntitute with double distilled water (DDW) to a concentration of 1.0 mg/mL.

    Konzentration

    1 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C, protected from the light, for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target

    MERTK (C-Mer Proto-Oncogene Tyrosine Kinase (MERTK))

    Andere Bezeichnung

    MERTK

    Hintergrund

    Receptor tyrosine kinase MerTK, C-Mer Proto-Oncogene Tyrosine Kinase, Mer, Proto-Oncogene C-Mer,Myeloid-epithelial-reproductive tyrosine kinase, MERTK, is a receptor tyrosine kinase of the TAM (Tyro3, Axl and MERTK) family, expressed in numerous cancers1.The extracellular N-terminal domain contains two immunoglobulin-like and two fibronectin 3 domains, followed by a hydrophobic single pass transmembrane domain, and a cytoplasmic C-terminal tail containing a tyrosine kinase domain1,2.Auto-phosphorylation induced by ligand binding influences a range of downstream signaling pathways and cellular functions2. The physiological roles of MERTK include regulation of tissue homeostasis and repair, innate immune control, and platelet aggregation. However, aberrant expression of this protein promotes neoplasia, cell cycle progression, proliferation and tumor growth, resistance to apoptosis, and promotion of tumor metastases.MERTK is involved in the activation of several canonic oncogenic signaling pathways in various types of cancers including: leukemia, non-small cell lung cancer, glioblastoma, melanoma, prostate cancer, breast cancer, colon cancer and gastric cancer1,3,4.Due to its pivotal role in cancer development and metastasis, multiple therapeutic approaches are currently in development to inhibit MERTK, including ligand "traps" and small-molecule tyrosine kinase inhibitors4.

    Alternative names: Receptor tyrosine kinase MerTK, C-Mer Proto-Oncogene Tyrosine Kinase, Mer, Proto-Oncogene C-Mer

    Gen-ID

    17289

    NCBI Accession

    NM_006343

    UniProt

    Q60805

    Pathways

    RTK Signalweg
Sie sind hier:
Chat with us!